The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022

OBJECTIVES: Health regulators have progressively increased their attention and focus on patient-reported outcomes (PROs), driven by the diffusion of a patient-centred approach to the drug development process. This study investigates the consideration of PROs and their measures (PROMs) in the authori...

Descripción completa

Detalles Bibliográficos
Autores principales: Meregaglia, Michela, Malandrini, Francesco, Angelini, Stefania, Ciani, Oriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627987/
https://www.ncbi.nlm.nih.gov/pubmed/37659000
http://dx.doi.org/10.1007/s40258-023-00827-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627987/
https://www.ncbi.nlm.nih.gov/pubmed/37659000
http://dx.doi.org/10.1007/s40258-023-00827-3

Ejemplares similares